744P A phase II study of ACR-368 in patients with ovarian (OvCa) or endometrial carcinoma (EnCa) and prospective validation of OncoSignature patient selection (NCT05548296)
| Autor: | Lee, J-M., MacLaughlan, S., Matei, D., Song, M., Brubaker, L., Rimmel, B., Eskander, R.N., Kyi, C., Williams, H., Duska, L., Musa, F., Coleman, R.L., Slomovitz, B.M., Gamelin, E.C., Cuillerot, J-M., Phadnis, M.M., Guercio, B., Crafton, S., Konstantinopoulos, P. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S564-S565 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|